These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 10924756

  • 1. Altered expression of cruzipain and a cathepsin B-like target in a Trypanosoma cruzi cell line displaying resistance to synthetic inhibitors of cysteine-proteinases.
    Yong V, Schmitz V, Vannier-Santos MA, de Lima AP, Lalmanach G, Juliano L, Gauthier F, Scharfstein J.
    Mol Biochem Parasitol; 2000 Jun; 109(1):47-59. PubMed ID: 10924756
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors.
    Lima AP, dos Reis FC, Serveau C, Lalmanach G, Juliano L, Ménard R, Vernet T, Thomas DY, Storer AC, Scharfstein J.
    Mol Biochem Parasitol; 2001 Apr 25; 114(1):41-52. PubMed ID: 11356512
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, is associated with enhanced metacyclogenesis.
    Tomas AM, Miles MA, Kelly JM.
    Eur J Biochem; 1997 Mar 01; 244(2):596-603. PubMed ID: 9119029
    [Abstract] [Full Text] [Related]

  • 7. Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors.
    Serveau C, Lalmanach G, Juliano MA, Scharfstein J, Juliano L, Gauthier F.
    Biochem J; 1996 Feb 01; 313 ( Pt 3)(Pt 3):951-6. PubMed ID: 8611180
    [Abstract] [Full Text] [Related]

  • 8. Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells.
    Santos CC, Sant'anna C, Terres A, Cunha-e-Silva NL, Scharfstein J, de A Lima AP.
    J Cell Sci; 2005 Mar 01; 118(Pt 5):901-15. PubMed ID: 15713748
    [Abstract] [Full Text] [Related]

  • 9. A fragment of the major histocompatibility complex class II-associated p41 invariant chain inhibits cruzipain, the major cysteine proteinase from Trypanosoma cruzi.
    Bevec T, Stoka V, Pungercic G, Cazzulo JJ, Turk V.
    FEBS Lett; 1997 Jan 20; 401(2-3):259-61. PubMed ID: 9013899
    [Abstract] [Full Text] [Related]

  • 10. Effects of proteinase inhibitors on the growth and differentiation of Trypanosoma cruzi.
    Franke de Cazzulo BM, Martínez J, North MJ, Coombs GH, Cazzulo JJ.
    FEMS Microbiol Lett; 1994 Nov 15; 124(1):81-6. PubMed ID: 8001773
    [Abstract] [Full Text] [Related]

  • 11. A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection.
    Doyle PS, Zhou YM, Engel JC, McKerrow JH.
    Antimicrob Agents Chemother; 2007 Nov 15; 51(11):3932-9. PubMed ID: 17698625
    [Abstract] [Full Text] [Related]

  • 12. A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes.
    Aparicio IM, Scharfstein J, Lima AP.
    Infect Immun; 2004 Oct 15; 72(10):5892-902. PubMed ID: 15385491
    [Abstract] [Full Text] [Related]

  • 13. Cruzipain Activates Latent TGF-β from Host Cells during T. cruzi Invasion.
    Ferrão PM, d'Avila-Levy CM, Araujo-Jorge TC, Degrave WM, Gonçalves Ada S, Garzoni LR, Lima AP, Feige JJ, Bailly S, Mendonça-Lima L, Waghabi MC.
    PLoS One; 2015 Oct 15; 10(5):e0124832. PubMed ID: 25938232
    [Abstract] [Full Text] [Related]

  • 14. Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi.
    Engel JC, Doyle PS, Palmer J, Hsieh I, Bainton DF, McKerrow JH.
    J Cell Sci; 1998 Mar 15; 111 ( Pt 5)():597-606. PubMed ID: 9454733
    [Abstract] [Full Text] [Related]

  • 15. Decoding the anti-Trypanosoma cruzi action of HIV peptidase inhibitors using epimastigotes as a model.
    Sangenito LS, Menna-Barreto RF, D Avila-Levy CM, Santos AL, Branquinha MH.
    PLoS One; 2014 Mar 15; 9(12):e113957. PubMed ID: 25464510
    [Abstract] [Full Text] [Related]

  • 16. Upregulation of the secretory pathway in cysteine protease inhibitor-resistant Trypanosoma cruzi.
    Engel JC, Torres C, Hsieh I, Doyle PS, McKerrow JH.
    J Cell Sci; 2000 Apr 15; 113 ( Pt 8)():1345-54. PubMed ID: 10725218
    [Abstract] [Full Text] [Related]

  • 17. Human T cell responses against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi: role of the multifunctional alpha 2-macroglobulin receptor in antigen presentation by monocytes.
    Morrot A, Strickland DK, Higuchi Mde L, Reis M, Pedrosa R, Scharfstein J.
    Int Immunol; 1997 Jun 15; 9(6):825-34. PubMed ID: 9199965
    [Abstract] [Full Text] [Related]

  • 18. The major cysteine proteinase of Trypanosoma cruzi: a valid target for chemotherapy of Chagas disease.
    Jose Cazzulo J, Stoka V, Turk V.
    Curr Pharm Des; 2001 Aug 15; 7(12):1143-56. PubMed ID: 11472258
    [Abstract] [Full Text] [Related]

  • 19. Trypanosoma cruzi: insights into naphthoquinone effects on growth and proteinase activity.
    Bourguignon SC, Cavalcanti DF, de Souza AM, Castro HC, Rodrigues CR, Albuquerque MG, Santos DO, da Silva GG, da Silva FC, Ferreira VF, de Pinho RT, Alves CR.
    Exp Parasitol; 2011 Jan 15; 127(1):160-6. PubMed ID: 20647011
    [Abstract] [Full Text] [Related]

  • 20. Some kinetic properties of a cysteine proteinase (cruzipain) from Trypanosoma cruzi.
    Cazzulo JJ, Cazzulo Franke MC, Martínez J, Franke de Cazzulo BM.
    Biochim Biophys Acta; 1990 Feb 09; 1037(2):186-91. PubMed ID: 2407295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.